Aim: Elevated maternal serum uric acid is associated with small-for-gestational-age (SGA) fetuses. We investigated whether uric acid concentrations in normotensive pregnant women are correlated with fetal growth and related to kidney function. Methods: We carried out a case-control study using 40 patients who delivered SGA fetuses identified from the perinatal database and 80 patients who delivered appropriate-for-gestational-age (AGA) fetuses as the controls at Okayama University Hospital. Blood pressure, serum uric acid and creatinine level were measured in the patients’ third trimester. Results:Maternal serum uric acid (p = 0.0003) and creatinine (p < 0.0001) concentrations, as well as systolic and diastolic blood pressures (p =0.014 and 0.037, respectively), were significantly increased in the SGA group. There was a strong negative correlation between serum uric acid levels and birth weights (r = –0.59; p = 0.006) and a significant positive correlation between maternal serum uric acid and creatinine levels (r = 0.43; p < 0.05) in cases of severe SGA (<5th percentile). Multiple linear regression analysis indicated that uric acid is an independent risk factor for SGA.Conclusions: Increasing maternal uric acid concentrations were associated with slightly impaired kidney function and SGA in normotensive pregnant women.

1.
Boyle JA, Campbell S, Duncan AM, Greig WR, Buchanan WW: Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol 1966;19:501–513.
2.
Dunlop W, Davison JM: The effect of normal pregnancy upon the renal handling of uric acid. Br J Obstet Gynaecol 1977;84:13–21.
3.
Lind T, Godfrey KA, Otun H, Philips PR: Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984;91:128–132.
4.
Semple PF, Carswell W, Boyle JA: Serial studies of the renal clearance of urate and inulin during pregnancy and after the puerperium in normal women. Clin Sci Mol Med 1974;47:559–565.
5.
Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ: Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002;40:355–360.
[PubMed]
6.
Bainbridge SA, Roberts JM: Uric acid as a pathogenic factor in preeclampsia. Placenta 2008;29Suppl A:S67–S72.
7.
Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888–2897.
[PubMed]
8.
Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553–3562.
[PubMed]
9.
Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991–F997.
[PubMed]
10.
Redman CW, Beilin LJ, Bonnar J, Wilkinson RH: Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976;1:1370–1373.
11.
Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW: Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263–1269.
12.
Laughon SK, Catov J, Roberts JM: Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. Am J Obstet Gynecol 2009;201:582.e1–e6.
13.
Hjortnaes J, Algra A, Olijhoek J, Huisman M, Jacobs J, van der Graaf Y, Visseren F: Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. J Rheumatol 2007;34:1882–1887.
[PubMed]
14.
López-Suárez A, Elvira-González J, Bascuñana-Quirell A, Rosal-Obrador J, Michán-Doña A, Escribano-Serrano J, Benítez-Rodríguez E: Grupo para el Estudio del Riesgo Vascular Alcalá: Serum urate levels and urinary uric acid excretion in subjects with metabolic syndrome. Med Clin (Barc) 2006;126:321–324.
15.
Puig JG, Martinez MA, Mora M, Fraile JM, Montoya F, Torres RJ: Serum urate, metabolic syndrome, and cardiovascular risk factors. A population-based study. Nucleosides Nucleotides Nucleic Acids 2008;27:620–623.
16.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–470.
[PubMed]
17.
Smith MC, Moran P, Ward MK, Davison JM: Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 2008;115:109–112.
[PubMed]
18.
Bainbridge SA, von Versen-Hoynck F, Roberts JM: Uric acid inhibits placental system an amino acid uptake. Placenta 2009;30:195–200.
19.
Rott KT, Agudelo CA: Gout. JAMA 2003;289:2857–2860.
20.
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183–1190.
[PubMed]
21.
Puig JG, Martinez MA: Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008;20:187–191.
22.
Chang FM, Chow SN, Huang HC, Hsieh FJ, Chen HY, Lee TY, Ouyang PC, Chen YP: The placental transfer and concentration difference in maternal and neonatal serum uric acid at parturition: comparison of normal pregnancies and gestosis. Biol Res Pregnancy Perinatol 1987;8:35–39.
23.
DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ: Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004;66:281–287.
24.
Weisz B, Cohen O, Homko CJ, Schiff E, Sivan E: Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance. Am J Perinatol 2005;22:139–144.
You do not currently have access to this content.